NEOVE FLUNIXIN MEGLUMINE INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neove flunixin meglumine injection

neove pharma australia pty limited - flunixin meglumine - parenteral liquid/solution/suspension - flunixin meglumine benzene active 50.0 mg/ml - musculoskeletal system - cattle | dog | horse | pigs | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castra - analgesic | anti-inflammatory agent | antiprostaglandin | antipyretic | bone soreness | bruising | bursitis | colic | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon sprains | traumatic swelling

MULTIHANCE INJECTION 10 ML Singapore - English - HSA (Health Sciences Authority)

multihance injection 10 ml

dch auriga singapore - gadobenate dimeglumine; gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml; gadobenate dimeglumine 529 mg/ml

FLUNIXIN- flunixin meglumine injection, solution United States - English - NLM (National Library of Medicine)

flunixin- flunixin meglumine injection, solution

norbrook laboratories limited - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - horse: flunixin injection is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixin injection is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixin injection is also indicated for the control of inflammation in endotoxemia. horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of partur

VETAMEG- flunixin meglumine injection, solution United States - English - NLM (National Library of Medicine)

vetameg- flunixin meglumine injection, solution

aspen veterinary resources - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - horse: vetameg® 50 mg/ml is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: vetameg® 50 mg/ml is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. vetameg® 50 mg/ml is also indicated for the control of inflammation in endotoxemia. horse: there are no known contra-indications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of partu

PREVAIL- flunixin meglumine injection, solution United States - English - NLM (National Library of Medicine)

prevail- flunixin meglumine injection, solution

mwi veterinary supply co - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - horse: prevail® is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: prevail® is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. prevail® is also indicated for the control of inflammation in endotoxemia. horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flu

FLUNIXIN- flunixin meglumine injection, solution United States - English - NLM (National Library of Medicine)

flunixin- flunixin meglumine injection, solution

vettek - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse: flunixin injection (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixin injection (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixin injection is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle : nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of still birth. do not use flunixin injection (flunixin meglumine injection) within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected.

FLUNAZINE-S- flunixin meglumine injection, suspension United States - English - NLM (National Library of Medicine)

flunazine-s- flunixin meglumine injection, suspension

bimeda, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 100 ml - indication flunazine-s (flunixin meglumine injection) is indicated for the control of pyrexia associated with swine respiratory disease. contraindications there are no known contraindications to this drug in swine when used as directed. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration is suspected.

PREVAIL- flunixin meglumine injection, solution United States - English - NLM (National Library of Medicine)

prevail- flunixin meglumine injection, solution

mwi veternary supply, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400), phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - flunixin meglumine 50 mg in 1 ml - indications    horse : prevail™ (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse.    cattle : prevail™ (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. prevail™ is also indicated for the control of inflammation in endotoxemia. contraindications    horse : there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle : nsaids inhibit pr

PREVAIL- flunixin meglumine solution United States - English - NLM (National Library of Medicine)

prevail- flunixin meglumine solution

vetone/mwi - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse: prevail™ (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: prevail™ (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. prevail™ is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the inhibition of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use prevail™ (flunixin meglumine injection) within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected.

hypaque sodium- Diatrizoate Meglumine injection, solution United States - English - NLM (National Library of Medicine)

hypaque sodium- diatrizoate meglumine injection, solution

amersham health inc. - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - injection, solution - 60 g in 100 ml - hypaque meglumine 60 percent is indicated for excretory urography; cerebral angiography; peripheral arteriography; venography; operative, t-tube, or percutaneous transhepatic cholangiography; splenoportography; arthrography; discography; and contrast enhancement of computed tomographic head imaging. diatrizoate salts are used in small, medium, and large dose urography (see dosage and administration-excretory urography). visualization of the urinary tract can be achieved by either direct intravenous bolus injection, intravenous drip infusion, or incidentally following intra-arterial procedures. visualization of the urinary tract is delayed in infants less than 1 month old, and in patients with urinary tract obstruction (see clinical pharmacology). injectable radiopaque contrast media may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized. radiopaque diagnostic agents may be useful to investigate the presence and extent of certain malignancie